The
Politics of Pain
By: Judy
Foreman
11/04/03
This is the first of a two part column
on pain.
America is
seriously schizophrenic about controlling chronic pain, which
afflicts more than 50 million people and costs the country $100
billion a year.So On the one hand, we grossly under-treat it:
Management of chronic pain and the pain of dying patients is
arguably the most egregiously neglected field of medicine.
On the other hand, as a society, we have become obsessed with the
war on drugs -- and the fear of addiction to opioids (narcotics).
Pain patients who were functioning well on morphine-like drugs
such as oxycodone (OxyContin) are now fearful of them -- or just
plain can't get them.
Some drug stores, wary of robberies of OxyContin, are afraid to
stock it. Some unscrupulous doctors have written excessive
prescriptions for it. Some
patients, like talk show host Rush Limbaugh, abuse it as well. And
in some states, Medicaid regulations require doctors to get prior
authorization before prescribing the drug. The basic problem is
obvious: Some of the drugs that most effectively treat pain are
the same ones that are commonly abused. In one survey of New York
doctors, 30 percent said they were prescribing fewer opioids or
were switching patients to less-effective pain medications for
fear that the Drug Enforcement Agency (DEA) might investigate
them. At the root of our national ambivalence is what June L.
Dahl, professor of pharmacology at the University of
Wisconsin-Madison Medical School, calls "opiophobia" --
the fear of addiction to opioids. That phobia has led to serious
undertreatment of pain -- particularly
chronic pain.
"Every bit of evidence suggests that we have been
under-treating pain," said Dr. Kathleen Foley, an attending
neurologist at the Memorial Sloan-Kettering Cancer Center and
director of the Project on Death in America of the Open Society
Institute, an operating foundation supported by George Soros. In
the last five years alone, three major reports from the Institute
of Medicine, an arm of the National Academy of Sciences, have
concluded that pain control in this country is woefully
inadequate.
These pronouncements follow a 1995 study by the Robert Wood
Johnson Foundation that found that 50 percent of people had
moderate to severe pain in the last three days of life. A separate
study found similar rates of untreated pain in dying children.
Even the US Supreme Court, in deciding in 1997 against a
constitutional right to physician-assisted suicide, highlighted
the need for better pain control and palliative care. Though the
fear of addiction is great, in reality, the risk is small,
when patients take drugs in the doses prescribed by
physicians.
"Addiction,"
to be sure, is a loaded word. Researchers prefer to speak of
physical dependence, which does occur in patients taking opioids,
and psychological dependence, which typically does not. It is
psychological dependence -- a compulsion to seek more and more of
the drug, despite the harm it causes -- that lay people usually
mean by "addiction." One 1982 study on patients in 93
burn facilities found no evidence that any patients became
addicted to opioids. More recent data from pain clinics suggest
the addiction rate might be around 10 percent, but people who
attend pain clinics are not typical of all pain patients.
Moreover, though
opioids can cloud the mind, they don't damage vital organs such as
the liver, stomach and kidneys, notes Foley of Sloan-Kettering.
And once doses are adjusted correctly and monitored by a doctor,
patients on opioids for chronic pain often function "at high
levels," including taking care of families and even driving,
she said.
Dr. James Rathmell, chairman of the committee on pain medicine for
the American Society of Anesthesiologists and professor of
anesthesia at the University of Vermont College of Medicine in
Burlington, puts it even more forcefully.
Fears of
addiction? "Forget it," he said. "If you have
intractable cancer pain, addiction should be the farthest worry
from your mind. Addiction is very unlikely. There are wonderful
medications that provide continuous relief over time." That
is true for non-cancer pain as well, although aggressive control
of pain for non-lethal diseases is even more controversial.
Arthritis, both
rheumatoid and osteoarthritis, affect an estimated 70 million
Americans, said Dr. John Klippel, medical director of the
Arthritis Foundation. Yet many suffer daily because their pain is
inadequately controlled.
With rheumatoid arthritis, one way of controlling the pain is by
treating the underlying inflammatory disease itself, with drugs
called DMARDS, disease-modifying anti-rheumatic drugs such as
methotrexate. In addition,non-steroidal anti-inflammatory drugs
such as ibuprofin (Motrin) and COX -2 inhibitors (like Vioxx and
Celebrex) can help.
And despite
America's conflicted views, there are signs that we're overcoming
our collective phobia. Last month, the American Academy of Pain
Medicine and leading doctors announced a new initiative called Top
Med which will provide a web-based "virtual textbook"
available free to all medical students across the country.
It is sorely needed. At the moment, only 3 percent of medical
schools have a separate, required course on pain management and
only 4 percent require a course in end-of-life care, according to
a 2000-2001 survey of 125 medical schools by the Association
of American Medical Colleges. A new survey (2003) shows that most
medical schools now cover these topics as part of existing
required courses.
There's other good news, too. In 2001, the Joint Commission for
the Accreditation of Healthcare Organizations (JCAHO), the group
that accredits the vast majority of the nation's hospitals,
mandated that hospitals must assess and manage pain for all
patients, something that, astonishingly enough, had not been done
routinely until then. On a more grass roots level, almost all
states (including Massachusetts, California and Maryland) have
launched pain initiatives to reduce legislative barriers to
effective pain control.
Many states are
also establishing electronic systems to monitor prescribing and
dispensing of controlled substances -- a tricky business because
the idea is to protect against abuse while not restricting access
for people who need opioids. Nationally, there is a controversial
bill pending in Congress dubbed NASPER (National All Schedules
Prescription Electronic Reporting Act) that would do much the same
thing. Klippel of the Arthritis Foundation said what pain control
-- for arthritis sufferers and others in chronic pain -- should
ultimately come down to is quality of life.
Patients should
realize, he said, that, when taken properly, "the potential
for addiction
is really minimal.”
Judy
Foreman is a Lecturer on Medicine at Harvard Medical School.
Her column appears every other week. Past columns are
available on www.myhealthsense.com.
To Pain
To
2003 General
Medicine